icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Canadian Market Projected Growth

  Marijuana for Trauma has one of the largest networks of cannabis clinics in Canada, representing more than 6% of all Canadian medical patients through the Knalysis software platform. Knalysis data indicates that prescription amounts are slightly higher for men than women. While prescription volumes may be similar, reasons behind prescriptions vary by gender, severity, […]
Read more
Canada Marijuana Legalization Timeline

Diagnosing Why Canada’s Medical Market Should Thrive

By J.J. McCoy, Senior Managing Editor for New Frontier Data Despite some recent angst about whether there will be a sufficient supply of cannabis to meet the needs of registered medical patients as Canada rolls out its nationwide adult-use program, there is reason for keeping confident about the future of its medical cannabis market. As detailed in […]
Read more

Canadian Market Projected Growth

  The total legal cannabis market forecast for Canada is to reach CAD$1.7 billion (USD$1.4B) in 2018, growing to CAD$7.7 billion (USD$6.1B) by 2025. The overall cannabis market (illicit + legal) forecast is for CAD$8.6 billion in 2018 (USD$6.4B), growing to CAD$9.2 billion (USD$7.3B) by 2025. While the forthcoming rollout of Canada’s adult-use market is […]
Read more

New Green Rush in the Great White North

By J.J. McCoy, Senior Managing Editor for New Frontier Data A year ago this month, Canadian Prime Minister Justin Trudeau struck a watershed moment for cannabis reform worldwide in announcing a comprehensive plan for a nationwide, adult-use market. Though his initial goal of a rollout by July 1 of this year is yet to manifest itself […]
Read more

Something to Declare: Legalized Cannabis Leads to Fewer Border Interceptions

By J.J. McCoy, Senior Managing Editor for New Frontier Data Nationally, reported interceptions of cannabis by the U.S. Customs and Border Protection have been falling dramatically throughout recent years, from 2.53 million pounds in 2011, to 861,231 pounds in 2017 -- a 66% decrease. That dramatic decline mirrors the increase in domestic cannabis production as more […]
Read more

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

By Greg Chin, Kevin Michaelan and Jeffrey Michelson, Partner Continuing with the topic of industry trends from our last post, we explore the art of acquisition-side due diligence from full-scope financial and tax to limited-scope tax-only engagements.  We’ll look at what to expect and how to approach it.  Although commonly geared toward the investor/acquirer, i.e., […]
Read more

Slowing the Tide of Imported Cannabis

  Reported interceptions of illicit cannabis by the U.S. Customs and Border Protection nationwide have fallen from 2.53 million pounds in 2011, to 861,231 pounds in 2017: a 66% decrease. The consistent declines inversely reflect increases in domestic cannabis production as more U.S. states legalize cannabis whether for medical programs, adult-use markets, or both. Year-over-year […]
Read more

CBD Impact on Healthcare

  Wholesale prices in maturing U.S. adult-use cannabis markets keep declining, with the Average Market Rate (AMR) in Colorado falling to $1,012, half that of 2014’s market launch. AMR, which sets growers’ excise tax liability, varies across markets: In Nevada, the average flower rate is $2,268, more than 2x that of Colorado’s, while other markets […]
Read more

Suddenly, A Season for Industrial Hemp to Spring Forward

By J.J. McCoy, Senior Managing Editor for New Frontier Data Last year, cannabis-industry attorney Bob Hoban told us how he saw “the hemp industry taking huge, huge, huge steps forward. I’ve always seen and still maintain that the hemp industry is going to dwarf the marijuana industry by a long, long, long shot. The hemp industry worldwide […]
Read more

Medical Cannabis, Texas-Style: Conditions and Requirements for Use

By Ashley Simpson, Hoban Law Group In 2015, the Texas legislature’s passage of the Texas Compassionate Use Act (Senate Bill 339) legalized medical cannabis in the Lone Star State, but only to the extent of "low-THC cannabis oil" for use by patients diagnosed with intractable epilepsy. Widening further access to any patients respectively diagnosed with […]
Read more